Given that impaired autophagy and mitochondrial dysfunction are two prominent features of neurodegenerative diseases, the neuroprotective effects of Drp1 inhibition mediated through improved autophagy flux (as shown in this study) and mitochondrial function (as reported in other studies) make this protein an even more attractive therapeutic target. The gene discussed is DNM1L; the disease is neurodegenerative disease.